mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.015 |
0.9 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
1 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.018 |
1 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.0017 |
1 |